News

Journal watch: Trial sheds light on optimal management of brain arteriovenous malformation

6036 4024 Anna Stelling, PhD

The Background There has been longstanding uncertainty of whether medical management alone or additional interventional therapy is better for patients with a brain arteriovenous malformation that has never bled. Reports…

read more

Head impacts associated with depression and decreased cognitive function

6000 4000 Anna Stelling, PhD

Current research suggests that repetitive head impacts (RHI) resulting from contact sports, military service, domestic violence, or other sources are associated with cognitive and neuropsychiatric disorders.1 It has been proposed…

read more

CONy 2020

4896 3264 Anna Stelling, PhD

The world Congress on Controversies in Neurology (CONy) this year will take place from the 2nd until the 5th of October 2020 on a virtual platform. The congress will cover…

read more

Researchers found how ketamine works in depression – but that’s not all

6016 4016 Anna Stelling, PhD

Depression is a widely-spread disease, with over 264 million people being affected worldwide.1 For a subset of patients suffering from major depressive disorder (MDD), administering low doses of the anaesthetic…

read more

Malaria drug brings new hope for glioblastoma patients

4794 3196 Anna Stelling, PhD

Glioblastoma is a very aggressive form of cancer. Even though there is a low number of patients who live longer than 5 years after diagnosis – a statistic that researchers…

read more

Does COVID-19 affect the brain?

1920 1080 Anne Carter, MA (Cantab)

With EAN going virtual this year, the global SARS-CoV2 pandemic was never far from the attendees’ minds. After a brief overview of the putative mechanisms for SARS-CoV2 accessing the brain,…

read more
Brain, Man, Alzheimers

Optimising early diagnosis of Alzheimer’s disease – mission impossible?

1920 1080 Anna Stelling, PhD

Alzheimer’s disease (AD) is a very common malady of the elderly, currently affecting 5.8 million Americans above the age of 65. It accounts for 60–80% of all dementia cases, which…

read more
Sun, ray of light, forest, trees

Siponimod shows promising long-term efficacy in SPMS patients

1920 1280 Anna Stelling, PhD

While researchers are looking at the potential of stem cells in the treatment of multiple sclerosis (MS), novel, promising immune-modulating therapies are being developed. At this year’s virtual EAN Congress,…

read more

Paediatric multiple sclerosis: Adding to our knowledge

1920 1080 Anne Carter, MA (Cantab)

Data suggest that between 2 and 5% of patients with multiple sclerosis (MS) are under 18 years old,1 yet there is only one approved treatment option in this population.2,3 During…

read more
Elderly man on bench by himself outdoors

Why do some glioblastoma patients live longer than others?

1920 1280 Anna Stelling, PhD

Why do some glioblastoma patients live longer than others? Alice Laurenge (Institut du Cerveau et de la Moelle épinière, Sorbonne Université and Hôspitaux universitaire La Pitié Salpêtrière – Charles Foix,…

read more
Brainwork is supported by unrestricted grants from: